Drug interactions
Indacaterol inhaled + Sunitinib
Severity: Minor
Indacaterol inhaled and Sunitinib: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Indacaterol, a beta-2 agonist, can prolong QTc at high exposure, and sunitinib also prolongs QT. The risk with inhaled doses is small but may add to arrhythmia risk in susceptible patients.
What this interaction means in plain words
Indacaterol inhaled and Sunitinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Why it happens
Additive effects on cardiac repolarization; beta-agonist hypokalemia may contribute.
What to do
Use usual indacaterol doses and monitor ECG and potassium in patients with cardiac disease or other QT risk factors.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Indacaterol inhaled and Sunitinib, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Sunitinib
- Adagrasib + Sunitinib Major
- Amiodarone + Sunitinib Major
- Amisulpride + Sunitinib Major
- Anagrelide + Sunitinib Major
- Apalutamide + Sunitinib Major
- Arsenic trioxide + Sunitinib Major
Frequently asked questions
Can I take Indacaterol inhaled with Sunitinib?
MediHelp rates the interaction as minor. Indacaterol inhaled and Sunitinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Indacaterol, a beta-2 agonist, can prolong QTc at high exposure, and sunitinib also prolongs QT. The risk with inhaled doses is small but may add to arrhythmia risk in susceptible patients.
How serious is the interaction between Indacaterol inhaled and Sunitinib?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Use usual indacaterol doses and monitor ECG and potassium in patients with cardiac disease or other QT risk factors.
What other medicines interact with Sunitinib?
MediHelp also lists interactions of Sunitinib with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Sunitinib page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
